HRB Reports 24% Rise in Cocaine Treatment Cases to 15,422 in 2025
The Health Research Board reported a 24% increase in cocaine treatment cases in Ireland, reaching 15,422 in 2025. Cocaine remains the most common drug treated, excluding alcohol, accounting for 42% of all cases. This rise reflects both increased drug use and expanded access to publicly funded treatment services.
The Health Research Board (HRB) has reported a significant increase in treatment cases for cocaine and crack cocaine use, alongside a rise in treatments for new psychoactive substances and ketamine.
The HRB's 2025 report indicates that 15,422 individuals received treatment for problem drug use during the year. Cocaine remains the most prevalent drug for which treatment is sought in Ireland, excluding alcohol, accounting for 42% of all drug treatment cases. This figure represents a 24% increase compared to the previous year.
Cocaine is identified as the primary problem drug for more than half of individuals initiating treatment. Additionally, the report noted a small number of cases last year involving treatment for nitrous oxide misuse, with over half of these individuals aged 17 or younger.
Dr. Gráinne Gorman, Chief Executive of the HRB, stated that the report underscores the persistent prevalence of cocaine use in Irish society. She also highlighted that the findings reflect increased investment in publicly funded drug treatment services, thereby expanding access for more people struggling with problematic drug use.